bf/NASDAQ:GILD_icon.png

NASDAQ:GILD

Gilead Sciences, Inc.

  • Stock

USD

Last Close

123.40

06/11 22:23

Market Cap

85.65B

Beta: 0.40

Volume Today

7.26M

Avg: 5.58M

PE Ratio

16.30

PFCF: 11.99

Dividend Yield

3.91%

Payout:48.14%

    Description

    Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, an injection for intravenous use, ...Show More

    Earnings

    Earnings per Share (Estimate*)

    0.511.522.52017-05-022019-05-022021-04-292023-04-272024-11-05

    Revenue (Estimate*)

    2B4B6B8B2017-05-022019-05-022021-04-292023-04-272024-11-05

    *Estimate based on analyst consensus